The Merger Situation (Medicopharma NV and AAH Holdings plc) (Interim Provision) (Revocation) Order 1992

Statutory Instruments

1992 No. 2619

MONOPOLIES AND MERGERS

The Merger Situation (Medicopharma NV and AAH Holdings plc) (Interim Provision) (Revocation) Order 1992

Made

21st October 1992

Laid before Parliament

21st October 1992

Coming into Force

21st October 1992

The Secretary of State, in exercise of the powers conferred on him by section 89(2) and (3)(a) and (b) and section 134(2) of the Fair Trading Act 1973(1)(2) hereby makes the following Order:–

1.  This Order may be cited as the Merger Situation (Medicopharma NV and AAH Holdings plc) (Interim Provision) (Revocation) Order 1992 and shall come into force forthwith.

2.  The Merger Situation (Medicopharma NV and AAH Holdings plc) (Interim Provision) Order 1992(3) is hereby revoked.

N. Hamilton

Parliamentary Under Secretary of State,

Department of Trade and Industry

21st October 1992

Explanatory Note

(This note is not part of the Order)

This Order revokes the Merger Situation (Medicopharma NV and AAH Holdings plc) (Interim Provision) Order 1992. The earlier Order was made with a view to achieving the purpose of an order which the Secretary of State had under consideration for remedying or preventing the adverse effects specified in the report of the Monopolies and Mergers Commission entitled “AAH Holdings plc/Medicopharma NV – a report on the merger situation” (Cm 1950, published by Her Majesty’s Stationery Office). The Secretary of State does not now have under consideration the form of order which he was considering when the earlier Order was made.

The earlier Order prohibited AAH Holdings plc and its subsidiaries from soliciting former customers in Grampian and Highland regions of Medicopharma NV or its subsidiaries and prohibited them from supplying goods to those former customers upon terms more favourable than the terms upon which they supplied goods to other customers in Scotland. The earlier Order also required AAH Holdings plc and its subsidiaries to maintain the value of assets acquired from Medicopharma or its subsidiaries and to keep them separate so that they could be disposed of.

(1)

1973 c. 41.

(2)

Section 89(2) was amended by the Companies Act 1989 (c. 40) Schedule 20, paragraph 15(2).

(3)

S.I. 1992/1115.